Clinical, epidemiological, pathological and surgical particularities, of patients with thyroid cancer
Keywords:
ultrasonography, thyroid neoplasms, cytodiagnosis, thyroidectomy.Abstract
Introduction: Thyroid cancer constitutes a reason of great concern and repercussion for the health of these patients. When being confirmed the diagnosis, a treatment protocol begins that generates big physical, psychic and social impacts.
Objective: To characterize patients with thyroid cancer according to clinical, epidemiological, pathological, and surgical variables.
Method: A descriptive, observational, cross-sectional and retrospective study of 153 patients surgically intervened with thyroid cancer, was carried out from January, 2012 to December, 2019. The instrument used was the observational quantitative and was processed by means of the SPSS statistical system, version 22.0.
Results: The sixth decade of life 37.2% and the female sex 89.5% prevailed in this series. In that same sense, 97.4% of patients suffered from a comorbidity and 42 cases were exposed to risk factors of malignancy that represent 27.4%. It is necessary to add that 64.7% of patients didn't have lymph node metastasis and were operated before the year of diagnosis. The multinodularity is involved in the most frequent clinical form with 52.2%. There was a prevalence of the TIRADS V echographic report and the cytologic Bethesda V0+I with 64.0% and 45.6% respectively. The predominant histologic variety was papillary with 54.9%. The thyroidectomy prevailed with 78.5% and as complication dysphonia with 6.0%.
Conclusions: Thyroid cancer is still a health problem and characterizing these patients was a contribution to the improvement of opportune diagnosis and personalization of the therapy in each patient.
Downloads
References
1. Kim J, Gosnell J, Roman S. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020. [citado20/02/2025];16(1):17-29. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31616074/
2. M Pizzato, M Li, J Vignat, M Laversanne, D Singh, and C La Vecchia. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022.[citado20/02/2025]; 10(4):264-272. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35271818/
3. Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China. J. Natl. Cancer Cent. 2022. [citado20/02/2025];4(1):47-53. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39036382/
4. Bravo-Villalta RR, Zambrano-Rodríguez KA, Durán-Cañarte AL. Prevalencia, factores de riesgo y diagnóstico del cáncer de tiroides en la población de América Latina. MQRInvestigar. 2024. [citado20/02/2025];8(1):2365-82. Disponible en: https://www.investigarmqr.com/ojs/index.php/mqr/article/view/1004
5. Siegel RL, Miller KD, Giaquinto AN, Jemal A. Cancer statistics. CA Cancer J Clin. 2024[citado20/02/2025];74(1):13-49. Disponible en: https://pubmed.ncbi.nlm.nih.gov/38230766/
6. Sociedad Española de Oncología Médica (SEOM). Las cifras del cáncer en España. 2024.[citado20/02/2025] Disponible en:
https://seom.org/images/publicaciones/informes-seom-de-evaluacion-de-farmacos/LAS_CIFRAS_2024.pdf
7. República de Cuba. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2023. La Habana: MINSAP; 2023. [citado 27/07/2024]. Disponible en: https://instituciones.sld.cu/ucmvc/files/2023/10/Anuario-Estad%C3%ADstico-de-Salud-2022-Ed-2023.pdf
8. Bogović Crnčić T, Ilić Tomaš M, Girotto N, Grbac Ivanković S. Risk factors for thyroid cancer: What do we know so far? Acta Clin Croat. 2020;[citado 27/07/2024];59(1):66-72. Disponible en: 10.20471/acc.2020.59.s1.08
9. Hoang JK, Middleton WD, Tessler FN. Update on ACR TI-RADS: Successes, challenges, and future directions, from the AJR Special Series on Radiology Reporting and Data Systems. AJR. 2021.[citado 21/02/2025];216:570–8. Disponible en: 10.2214/AJR.20.24608
10.Kraus Fischer G, Alvarado Bachmann R, de Rienzo Madero B, Núñez García E, Vega de la Peña M, Zerrweck López C. Correlación entre el sistema Bethesda de nódulos tiroideos y el diagnóstico histopatológico pos tiroidectomía. Rev Med Inst Mex Seguro Soc. 2020 [citado 16/08/2022];58(2):114-21. Disponible en: https://www.redalyc.org/journal/4577/457767703008/html/
11. The International Classification of Diseases, 10th Revision, Clinical modification. The National Center for Health Statistics (NHCS). 2024. citado [21/02/2025] Disponible en: https://www.cdc.gov/nchs/icd/icd-10-cm/?CDC_AAref_Val=https://www.cdc.gov/nchs/icd/icd-10-cm.htm
12. Cruz M, Pérez M. D, Jenaro C, Flores N, , Torres V. Implicaciones éticas para la investigación: El interminable reto en un mundo que se transforma. Horizonte Sanitario. 2020. [citado 16/08/2022];19(1):9-17.Disponible en: https://www.redalyc.org/articulo.oa?id=457868487002
13. Puerto-Lorenzo J, Torres-Aja L, Cabanes-Rojas E. Cáncer de tiroides: comportamiento en Cienfuegos. Rev Finlay. 2018. [citado 03/06/2024];8(2):[aprox. 8 p.]. Disponible en: https://revfinlay.sld.cu/index.php/finlay/article/view/444
14. Vera Ochoa JF, Suárez Lescano HB, Pilamunga Valla ER, Ortiz Álvarez MD, Montúfar Benítez OI. Cáncer de tiroides: perfil clínico-epidemiológico. jah. 2023 [citado 16/06/2024];6(1). Disponible en: https://jah-journal.com/index.php/jah/article/view/158
15. Arias-Ortiz Nelson E, Guzmán-Gallego Eduardo A. Características clínicas del cáncer de tiroides en Manizales, Colombia, 2008-2015. Rev. perú. med. exp. salud publica. 2020 [citado 01 /06/ 2025 ]; 37( 2 ): 287-291. Disponible en: http://dx.doi.org/10.17843/rpmesp.2020.372.4892.
16. Ortega-Peñate J, Díaz-Alfonso O, Cora-Abraham J, Méndez-Fleitas L, Ortega-Rodríguez Y. Comportamiento clínico-epidemiológico del cáncer de tiroides. Rev Méd Electrónica. 2020 [citado 31/03/2022];42(6):[aprox.10p.]. Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3979
17. Acosta Guerrero Gleidys, Delgado Llorca Fred, Ricardo Martínez Daimí, Guerra Corría Yamila. Caracterización clínica y epidemiológica de pacientes operados por cáncer de tiroides. Multimed. 2022. [citado 03/06/ 2024]; 26( 1 ). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-48182022000100008&lng=es
18. Mauri G, Gitto S, Cantisani V, Vallone G, Schiavone C, Papini E, et al. Use of the thyroid imaging reporting and data system (TIRADS) in clinical practice: an Italian survey. Endocrine. 2020;68(2): 329–35. Disponible en: 10.1007/s12020-020-02199-3
19. Bujaidar Tobias FA, Zatarain Bayliss L, Dehesa López E, Peraza Garay FJ. Incidencia de malignidad en nódulos tiroideos en pacientes sometidos a biopsia por aspiración con aguja fina guiada por ultrasonido. Rev Med UAS. 2020 [citado 16/08/2022];10(3):127-34. Disponible en: https://hospital.uas.edu.mx/revmeduas/articulos/v10/n3/tiroideos.pdf
20. Escalona-Veloz R. Utilización del sistema Bethesda para el diagnóstico citológico de nódulos tiroideos. MEDISAN. 2023 [citado 15/06/2024]; 27 (1). Disponible en: https://medisan.sld.cu/index.php/san/article/view/3395
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 MEDISAN

This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
